Please enable JS

DISCOVER

User Support

User support
is available in both
French
and english

This service falls within the scope of the ISO 9001 quality management system. Under the applicable contractual conditions, it participates in the Service Level Agreement.
The service is provided by our operational teams (levels 1 and 2) and technical teams (level 3).

picto access telemedicine user support

Access H24
via the WEB Portal

Please address your support requests via the WEB portal. You must have an access account.

Connexion

If you do not have an access account:

Request an access account
Email:

picto access telemedicine user support

Hotline

You can also access support via the hotline service.
Call number:

+33 1 55 20 08 02

Unless it is specified in the contract, the hotline is available during business hours: 9.30 a.m. – 6 p.m. (Paris – GMT+1)

picto access telemedicine user support

Remote call-out

Our hotliners have a commercial platform allowing, with the authorisation of the user, remote

Access request

to the “hotline” portal

A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT

64 +

countries
involved

20 000 +

investigational
Centres

3 million +

patients
in database

50 000 +

users
worlwide

telemedicine technologies earth

LATEST NEWSOUR NEWS >

telemedecine technologies news

Telemedicine Technologies will be at Swiss Biotech Day 2025

April 29, 2025

May 5 & 6 – Basel Telemedicine Technologies is pleased to present its CleanWeb™ eClinical suite, offering flexible, regulatory-compliant solutions tailored to every phase of clinical trials. Our platform includes a wide range of modules, such as eCRF, Randomization & Trial Supply Management, ePRO, eTMF, eConsent, Data Visualization, Vigilance, Imaging, CTMS, and more. We invite […]

READ MORE
telemedecine technologies news

Drug development cost pharma $2.2B per asset in 2024 as GLP-1s drive financial return

April 29, 2025

Fierce Biotech The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. The data come from 20 pharmas that had the highest R&D budgets in 2020, as reported in Deloitte’s annual report, “Measuring the return from pharmaceutical innovation.” In 2024, the average […]

READ MORE
telemedecine technologies news

Adopting Flexible Strategies to Combat Capacity Shortages

April 29, 2025

Biopharm International In January 2025, Samsung Biologics signed a six-year, $1.4 billion contract manufacturing agreement with an as-yet undisclosed European pharmaceutical company, with production to take place at Samsung’s manufacturing site in Songdo, South Korea (1). Simultaneously, at the J.P. Morgan Healthcare Conference held in San Francisco, the company announced plans to complete construction of […]

READ MORE

    ACCESS REQUEST

    Solution :